<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Mediterranean diet and metabolic outcomes in nafld/masld: A systematic review and meta-analysis of randomized controlled trials

dc.contributor.authorValenzuela-Fuenzalida, Juan José
dc.contributor.authorSalazar-Arancibia, Tamara
dc.contributor.authorLaborie-Reyes, Benjamin
dc.contributor.authorRodríguez-Ortiz, Francisco
dc.contributor.authorLoaiza Giraldo, Jessica Paola
dc.contributor.authorSalgado, Cristian
dc.contributor.authorNova-Baeza, Pablo
dc.contributor.authorOrellana-Donoso, Mathias
dc.contributor.authorMoya, Maria P.
dc.contributor.authorBruna Mejías, Alejandro
dc.contributor.authorCifuentes-Suazo, Gloria
dc.contributor.authorOyanedel-Amaro, Gustavo
dc.contributor.authorValenti, Vitor E.
dc.contributor.authorSanchis-Gimeno, Juan Alberto
dc.coverage.spatialPaíses Bajos
dc.date.accessioned2026-09-28T14:59:26Z
dc.date.available2026-09-28T14:59:26Z
dc.date.issued2026-10
dc.description.abstractNon-alcoholic fatty liver disease (NAFLD), recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD), is a leading cause of chronic liver disease worldwide. The Mediterranean diet (MD) is widely recommended for its metabolic benefits, but its specific impact on NAFLD/MASLD outcomes remains variable across trials. This systematic review and meta-analysis evaluated the effect of the Mediterranean diet on liver steatosis, liver enzymes, and metabolic markers in patients with NAFLD/MASLD. Larger, high-quality randomized trials with standardized dietary definitions and longer follow-up are required to clarify its therapeutic role in NAFLD/MASLD.
dc.identifier.citationClinical Nutrition ESPEN, Vol. 75 (2026) pp. 1-15
dc.identifier.doihttps://doi.org/10.1016/j.clnesp.2026.105017
dc.identifier.issne2405-4577
dc.identifier.orcidhttps://orcid.org/0000-0002-1781-062X
dc.identifier.urihttps://hdl.handle.net/20.500.12254/7744
dc.publisherElsevier Ltd.
dc.rightsAtribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL)
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/cl/
dc.subjectMediterranean diet
dc.subjectNAFLD
dc.subjectMASLD
dc.subjectNon-alcoholic fatty liver disease
dc.subjectMetabolic dysfunction-associated steatotic liver disease
dc.subjectSystematic review
dc.subjectMeta-analysis
dc.subjectRandomized controlled trials
dc.titleMediterranean diet and metabolic outcomes in nafld/masld: A systematic review and meta-analysis of randomized controlled trials
dc.typeArticle

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Paper 16 2026.pdf
Tamaño:
7,31 MB
Formato:
Adobe Portable Document Format

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
347 B
Formato:
Item-specific license agreed upon to submission
Descripción: